PYC Therapeutics
About:
PYC Therapeutics (ASX: PYC) is a development-stage biotechnology company pioneering a new generation of RNA therapeutics
Website: http://www.pyctx.com/
Description:
Total Funding Amount:
40M AUD
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Nedlands, Western Australia, Australia
Founded Date:
2005-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2024-03-14
IPO Status:
Public
Industries:
© 2025 bioDAO.ai